We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.07%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.4B
AUM Growth
-$1.57B
(-5.8%)
Cap. Flow
-$656M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
20.45%
Holding
1,233
New
125
Increased
407
Reduced
478
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$80.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$54M |
| 3 |
CVS Health
CVS
|
+$50.7M |
| 4 |
Agilent Technologies
A
|
+$41.4M |
| 5 |
Mastercard
MA
|
+$34.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$92.3M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$48.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$42M |
| 4 |
Lowe's Companies
LOW
|
+$35.4M |
| 5 |
Cadence Design Systems
CDNS
|
+$35.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.86% |
| 2 | Healthcare | 19.32% |
| 3 | Consumer Discretionary | 11.1% |
| 4 | Financials | 11.09% |
| 5 | Industrials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Invesco
IVZ
$13.9B
| – | – |
-200,400
| Closed | -$3.23M |
|
1127
Kulicke & Soffa
KLIC
$4.16B
| – | – |
-34,300
| Closed | -$1.47M |
|
1128
Knight Transportation
KNX
$11.1B
| – | – |
-7,161
| Closed | -$331K |
|
1129
L3Harris
LHX
$46.4B
| – | – |
-896
| Closed | -$217K |
|
1130
Matthews International
MATW
$624M
| – | – |
-11,500
| Closed | -$330K |
|
|
NIU
1131
Niu Technologies
NIU
$159M
| – | – |
-127,146
| Closed | -$1.09M |
|
1132
Annaly Capital Management
NLY
$16.5B
| – | – |
-8,640
| Closed | -$204K |
|
1133
NovoCure
NVCR
$1.81B
| – | – |
-10,296
| Closed | -$716K |
|
|
NXRT
1134
NexPoint Residential Trust
NXRT
$582M
| – | – |
-28,875
| Closed | -$1.8M |
|
1135
Okta
OKTA
$32.6B
| – | – |
-35,418
| Closed | -$3.2M |
|
1136
Olin
OLN
$1.92B
| – | – |
-69,800
| Closed | -$3.23M |
|
1137
Option Care Health
OPCH
$3.52B
| – | – |
-109,075
| Closed | -$3.03M |
|
1138
PENN Entertainment
PENN
$2.39B
| – | – |
-9,800
| Closed | -$298K |
|
1139
Children's Place
PLCE
$54M
| – | – |
-5,500
| Closed | -$214K |
|
1140
ePlus
PLUS
$2.4B
| – | – |
-25,650
| Closed | -$1.36M |
|
1141
Philip Morris
PM
$304B
| – | – |
-2,393
| Closed | -$236K |
|
1142
Insulet
PODD
$9.56B
| – | – |
-2,904
| Closed | -$633K |
|
1143
PTC
PTC
$14.2B
| – | – |
-65,513
| Closed | -$6.97M |
|
1144
QuidelOrtho
QDEL
$808M
| – | – |
-55,825
| Closed | -$5.43M |
|
1145
uniQure
QURE
$3.12B
| – | – |
-76,925
| Closed | -$1.43M |
|
1146
Roku
ROKU
$23B
| – | – |
-5,194
| Closed | -$427K |
|
1147
Red Rock Resorts
RRR
$3.24B
| – | – |
-10,700
| Closed | -$357K |
|
1148
Sunrun
RUN
$2.01B
| – | – |
-26,900
| Closed | -$628K |
|
1149
TD Synnex
SNX
$20.9B
| – | – |
-4,600
| Closed | -$419K |
|
1150
SPX Corp
SPXC
$9.18B
| – | – |
-38,375
| Closed | -$2.03M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2022 Portfolio in Review
As of Q3 2022, Axa held 1,233 positions worth $25.4B, down 5.8% from $27B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa's Q3 2022 filing shows 125 new, 407 increased, 478 reduced and 102 closed positions. Its largest new stake was Aspen Technology Inc: 133,226 shares worth $31.7M. The largest sale was Verizon, an estimated $92.3M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q3 2022 buy was Aspen Technology Inc: 133,226 shares worth $31.7M.
- Axa added most to Tesla in Q3 2022, an estimated $80.7M increase.
- Axa's biggest Q3 2022 reduction was Verizon, cutting an estimated $92.3M.
- Axa fully exited ZENDESK INC in Q3 2022, selling an estimated $48.4M.
- Axa's ten largest holdings make up 20% of its $25.4B portfolio in Q3 2022.
- Axa opened 125 new positions and closed 102 in Q3 2022.
- Axa's portfolio value fell 5.8% quarter-over-quarter to $25.4B.
Based on Axa's 13F filing for Q3 2022, filed 14 Nov 2022.